Automating Insurance Verification and Intake for Ketamine Therapy Practices

Ketamine therapy sits in a narrow corridor of healthcare demand that looks nothing like a typical specialty practice. The patient searching "is ketamine therapy safe for depression" has usually exhausted SSRIs, talk therapy, and sometimes inpatient stays. They are not browsing electively — they are treatment-resistant, often desperate, and making a high-stakes cash-pay decision under emotional duress. That demand character — urgent-feeling but elective in payer classification, almost entirely direct-to-consumer, and overwhelmingly out-of-pocket — creates an intake and verification workflow unlike anything in insurance-heavy medicine.

Your front desk isn't triaging emergencies or processing routine referrals. It's fielding calls from people who have already decided they want ketamine infusions but need to understand what their insurance will and won't touch before they commit. The friction isn't clinical — it's financial ambiguity. And that ambiguity, left unresolved for even a day, sends the patient to the next clinic in their search results.

Most Ketamine Services Are Cash-Pay, but the Verification Question Still Kills Conversions

Here's the payer reality you already know: ketamine infusions for mood disorders are almost universally not covered by commercial insurance. Spravato (esketamine) nasal spray occupies a different lane — it often has a coverage pathway, but with prior authorization requirements, REMS certification documentation, and step-therapy prerequisites that create their own verification burden.

A new patient calling your practice doesn't know which lane they're in. They don't know whether their plan covers Spravato, whether their depression diagnosis qualifies, or whether the six infusions they read about online will cost them $3,000 out of pocket. They just know they found "ketamine clinic near me reviews" and picked up the phone.

If your intake workflow can't answer the coverage question quickly — or at minimum triage the patient into the correct financial pathway (cash-pay infusion vs. insurance-eligible Spravato vs. hybrid) — that caller hangs up undecided. Undecided, in this vertical, means lost. They won't call back. They'll search again tomorrow and book with whoever resolves the ambiguity first.

The Spravato Prior Authorization Bottleneck Is Where Patients Stall for Days

For practices offering both IV ketamine infusions and Spravato, the intake split is operationally significant. A Spravato patient requires:

Verification of active behavioral health benefits
Confirmation that the plan covers esketamine specifically (not all do, even with mental health parity)
Documentation of failed trials on at least two oral antidepressants
Prior authorization submission, often with a turnaround of several business days
REMS enrollment paperwork completed before the first dose

Each of those steps is a point where the patient can fall out of your pipeline. If your front desk is manually calling payers to verify behavioral health benefits, then separately submitting prior auth, then following up on approval status — while also fielding new-patient calls — the lag compounds. A patient who called on Monday may not have a clear answer by Thursday. By then, they've found a cash-pay clinic that scheduled them for Wednesday.

Automating the eligibility check — running the patient's insurance ID through a real-time verification system the moment they submit intake information — collapses that first step from a phone call into seconds. You instantly know whether to route them toward the Spravato pathway or present the cash-pay infusion option with transparent pricing.

Intake Forms That Don't Ask the Right Depression-History Questions Waste Everyone's Time

Generic intake forms built for primary care or even general psychiatry miss the specific clinical and financial data points a ketamine practice needs before the first appointment. You need:

Current psychiatric medications (to assess interactions and to document for Spravato prior auth)
Number and names of previously failed antidepressants (the step-therapy requirement)
Current PHQ-9 or similar depression severity score (some payers require baseline documentation)
Whether the patient has a referring psychiatrist or is self-referred (this affects your documentation workflow)
Explicit acknowledgment of the cash-pay structure for IV infusions, including per-session and package pricing

When these questions are embedded in a digital intake form that the patient completes before their first call or visit, your staff isn't spending fifteen minutes on the phone extracting history. The patient self-selects into the correct pathway. Your verification system already has the insurance ID and can run eligibility in the background while the patient finishes their questionnaire.

The "Is This Covered?" Call Happens After Hours Because Patients Research at Night

People searching "is ketamine therapy safe for depression" are not doing so at 2 PM on a Tuesday. They're researching at 10 PM after a bad day, reading Reddit threads, watching YouTube testimonials, and then — if your practice appears credible — looking for a way to find out what it will cost them.

If your intake system only functions during business hours, you're asking a motivated, emotionally activated patient to remember to call tomorrow. Many won't. An automated intake flow that accepts submissions around the clock — collecting insurance information, running a preliminary eligibility check, and confirming receipt with an expected timeline for follow-up — captures that patient at the moment of highest intent.

This doesn't require a human at midnight. It requires a form that does more than collect a name and phone number. It requires logic: if the patient enters insurance information, the system checks eligibility and returns a preliminary result. If the patient indicates they're self-pay, it presents pricing and available appointment slots immediately.

Referral Coordination with Psychiatrists Is Lighter but Still Matters for Spravato Documentation

Ketamine therapy isn't referral-driven the way orthopedic surgery or cardiology is. Most patients are self-referred, arriving through direct search and word of mouth. But for Spravato specifically, having a referring psychiatrist's documentation of failed medication trials strengthens the prior authorization and speeds approval.

Your intake automation should ask whether the patient has a current psychiatrist and whether they can provide treatment records. If yes, an automated request for records — sent directly to the referring provider's office with the patient's signed release — removes a manual step that otherwise requires your staff to fax, call, and follow up.

This isn't about gatekeeping access. It's about assembling the documentation package that gets a prior auth approved on first submission rather than denied and resubmitted.

Transparent Pricing at Intake Eliminates the Biggest Objection Before It Becomes a No-Show

Because IV ketamine infusions are cash-pay, the single largest source of intake drop-off is price shock delivered too late in the process. If a patient completes intake, schedules a consultation, and only then learns that a six-infusion series costs several thousand dollars, you've wasted a consultation slot and lost the patient's trust.

Embedding pricing transparency into the intake flow — after the eligibility check confirms no insurance coverage for infusions — respects the patient's time and yours. It also pre-qualifies: patients who proceed past the pricing disclosure are genuinely ready to book. Your consultation becomes a clinical conversation, not a sales conversation.

Automated intake systems can present pricing conditionally: if eligibility returns negative for ketamine/esketamine coverage, the system displays your infusion pricing and payment options. If eligibility returns positive for Spravato, the system routes toward prior authorization and presents the expected copay or coinsurance.

Building the Workflow: Eligibility Check, Pathway Split, Scheduling

The operational sequence, reduced to its minimum:

Patient submits digital intake (available 24/7) with insurance ID, medication history, and depression screening.
System runs real-time eligibility verification against the patient's behavioral health benefits.
Based on result: patient is routed to Spravato pathway (prior auth initiated automatically) or cash-pay infusion pathway (pricing displayed, scheduling offered).
For Spravato: system generates prior auth request using intake data, submits electronically, and tracks status with automated follow-up.
For cash-pay: patient selects appointment slot and completes financial agreement digitally.
Staff reviews completed files each morning — no phone tag, no manual verification calls, no ambiguity about which pathway each patient belongs in.

This isn't theoretical. Each component — eligibility APIs, conditional form logic, electronic prior auth submission, online scheduling — exists as configurable tooling. The practice owner decides the logic, sets the pricing thresholds, and controls the routing rules. No agency manages it for you. You build it once, adjust it as payer policies shift, and your front desk handles exceptions rather than routine.

By Todd Whitaker, MBA

See how your local market breaks down — which ketamine therapy competitors are capturing search demand and where the intake gaps sit — so you can build your own automated workflow around real opportunity: See your market on Viotto